J&J Comprehensive Care Unit Will Disband As Company Consolidates
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson is scuttling the short-lived management group that oversees its stent, diagnostics, vision and diabetes businesses, citing a need to consolidate in the still shaky economy
You may also be interested in...
J&J Eyes Restructured Device Biz As New CEO Gorsky Steps In
Big changes are underway at J&J. In April, Alex Gorsky will become the company’s new CEO. And the firm plans a restructuring of its device business upon completion of its $20 billion-plus Synthes acquisition in the first half of the year.
Medtronic Consolidates Units Into Two Broad Groups
Medtronic says it hopes to improve efficiency by restructuring its businesses into two groups
Medtronic Consolidates Units Into Two Broad Groups
Medtronic says it hopes to improve efficiency by restructuring its businesses into two groups